What The Study Did: The 30-day incidence of outpatient and hospital-associated blood clots following SARS-CoV-2 testing among adults in a large health system was examined in this study.
Authors: Nareg H. Roubinian, M.D., of Kaiser Permanente Northern California in Oakland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2021.0488)
Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.0488?guestAccessKey=e8620d24-f35f-4089-9f59-36ca7d2db35f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040521
JAMA Internal Medicine